Area of research
Molecular Biology · Genetics
Research interest
Research interests include Muscle Physiology and Disorders, Pluripotent Stem Cells Research, Tissue Engineering and Regenerative Medicine, and Mesenchymal stem cell research.
Integrative transcriptomic profiling links telomere dysfunction to cGAS–STING activation in heart failure signatures in mice and humans
Neuromuscular impairment at different stages of human sarcopenia
Primary cilia on muscle stem cells are critical to maintain regenerative capacity and are lost during aging
Tissue Stem Cells: Architects of Their Niches
Farewell to Professor David Yaffe – A Pillar of the Myogenesis Field
Stem Cells in the Treatment of Disease
A Human iPSC Double-Reporter System Enables Purification of Cardiac Lineage Subpopulations with Distinct Function and Drug Response Profiles
Adult stem cells and regenerative medicine—a symposium report
Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M
Telomere shortening is a hallmark of genetic cardiomyopathies
Dermatologist-level classification of skin cancer with deep neural networks
An objective comparison of cell-tracking algorithms
Injectable biomimetic liquid crystalline scaffolds enhance muscle stem cell transplantation
Long telomeres protect against age-dependent cardiac disease caused by NOTCH1 haploinsufficiency
Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
The central role of muscle stem cells in regenerative failure with aging
Stem Cells and Aging: What’s Next?
Objective comparison of particle tracking methods
A benchmark for comparison of cell tracking algorithms
Non-invasive intravital imaging of cellular differentiation with a bright red-excitable fluorescent protein
Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
Tumor suppressors: enhancers or suppressors of regeneration?
Translating the Genomics Revolution: The Need for an International Gene Therapy Consortium for Monogenic Diseases
Therapeutic angiogenesis due to balanced single‐vector delivery of VEGF and PDGF‐BB